Parsing the free energy of anthracycline antibiotic binding to DNA

Biochemistry

Volumn 35, Issue 7, 1996, Pages 2047-2053

  Chaires, Jonathan B ^a   Satyanarayana, S ^a   Suh, Dongchul ^a   Fokt, Izabela ^b   Przewloka, Teresa ^b   Priebe, Waldemar ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 O (4 AMINO 2,4,6 TRIDEOXY ALPHA 1 HEXOPYRANOSYL)DAUNOMYCINONE; 9 DEOXYDOXORUBICIN; ADRIAMYCINONE; ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNOMYCINONE; DAUNORUBICIN; DAUNORUBICIN DERIVATIVE; DNA; DOXORUBICIN; HYDROXYRUBICIN; UNCLASSIFIED DRUG; WP 608;

ARTICLE; BINDING AFFINITY; DNA BINDING; DRUG DNA BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; LIGAND BINDING; MOLECULAR INTERACTION; PRIORITY JOURNAL;

AMINES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BINDING SITES; CATTLE; DNA; ELECTROCHEMISTRY; HYDROXYL RADICAL; STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS;

EID: 0030003572     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi952812r     Document Type: Article

References (42)

1. Ackers, G. K., & Smith, F. R. (1985) Annu. Rev. Biochem. 54, 597-629.
2. Burke, T. G., Mehta, R., Perez-Soler, R., & Priebe, W. (1993) Proc. Am. Assoc. Cancer Res. 84, 1971.
3. Cera, C., Palu, G., Magno, S. M., & Palumbo, M. (1991) Nucleic Acids Res. 19, 2309-2314.
4. Chaires, J. B. (1985) Biopolymers 24, 403-419.
5. Chaires, J. B. (1990a) Biophys. Chem. 35, 191-202.
6. Chaires, J. B. (1990b) in Molecular Basis of Specificity in Nucleic Acid-Drug Interactions (Pullman, B., & Jortner, J., Eds.) pp 123-136, Kluwer Academic Publishers, Dordrecht.
7. Chaires, J. B. (1995a) in Anthracycline Antibiotics, New Analogues, Methods of Delivery and Mechanisms of Action (Priebe, W., Ed.) ACS Symposium Series 574, pp 156-167, American Chemical Society, Washington, DC.
8. Chaires, J. B. (1995b) in Advances in DNA Sequence-Specific Agents (Hurley, L. H., & Chaires, J. B., Eds.) Vol. 2, JAI Press. Greenwich, CT (in press).
9. Chaires, J. B., Dattagupta, N., & Crothers, D. M. (1982) Biochemistry 21, 3933-3940.
10. Chaires, J B., Priebe, W., Graves, D. E., & Burke, T. G. (1993) J. Am. Chem. Soc. 115, 5360-5364.
11. Chen, K. X., Gresh, N., & Pullman, B. (1985) J. Biomol. Struct. Dyn. 3, 445-466.
12. Chen, K. X., Gresh, N., & Pullman, B. (1986) Mol. Pharmacol. 30, 279-286.
13. Correia, J. J., & Chaires, J. B. (1994) Methods Enzymol. 240, 593-614.
14. Friedman, R. A. G., & Manning, G. (1984) Biopolymers 23, 2671-2714.
15. Fritzsche, H., & Berg, H. (1987) Gazz. Chim. Ital. 117, 331-352.
16. Fritzsche, H., & Walter, A. (1989) in Chemistry & Physics of DNA-Ligand Interactions (Kallenbach, N. R., Ed.) pp 1-35, Adenine Press, Schenectady, NY.
17. Gresh, N., Pullman, B., Arcamone, F., Menozzi, M., & Tonani, R. (1989) Mol. Pharmacol. 35, 251-256.
18. Hawley, R. C., Kiessling, L. L., & Schreiber, S. L. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 1105-1109.
19. Horton, D., Priebe, W., & Varela, O. (1984) J. Antibiot. 37, 853-858.
20. Jencks, W. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 4046-4050.
21. Kennard, O., & Salisbury, S. A. (1993) J. Biol. Chem. 268, 10701 - 10704.
22. Li, T., Zeng, Z., Estevez, V. A., Baldenius, K. U., Nicolaou, K. C., & Joyce, G. F. (1994) J. Am. Chem. Soc. 116, 3709-3715.
23. Lohman, T. M., & Mascotti, D. M. (1992) Methods Enzymol. 212, 400-424.
24. Mark, A. E., & van Gunsteren, W. F. (1994) J. Mol. Biol. 240, 167-176.
25. Mathews, C. K., & van Holde, K. E. (1990) Biochemistry, p 298, Benjamin/Cummings Publishing Co., Inc., Redwood City, CA.
26. Mueller, W., & Crothers, D. M. (1968) J. Mol. Biol. 35, 251-290.
27. Pohle, W., Bohl, M., Flemming, J., & Böhlig, H. (1990) Biophys. Chem. 35, 213-226.
28. Priebe, W. (1995) Anthracycline Antibiotics, New Analogues, Methods of Delivery and Mechanisms of Action (Priebe, W., Ed.) ACS Symposium Series 574, American Chemical Society, Washington, DC.
29. Pullman, B. (1989) Adv. Drug Res. 18, 1-113.
30. Pullman, B. (1991) Anti-Cancer Drug Des. 7, 96-105.
31. Record, M. T., Jr., & Spolar, R. S. (1990) in The Biology of Nonspecific DNA-Protein Interactions (Revzin, A., Ed.) pp 33-69, CRC Press, Boca Raton, FL.
32. Record, M. T., Jr., Ha, H.-H., & Fisher, M. A. (1991) Methods Enzymol. 208, 291-342.
33. Rizzo, V., Battistini, C., Vigevani, A., Sacchi, N., Rizzano, G., Arcamone, F., Garbesi, A., Colonna, F. P., Capobianco, M., & Tondelli (1989) J. Mol. Recognit. 2, 132-141.
34. Roche, C. J., Berkowitz, D., Sulikowski, G. A., Danishefsky, S. J., & Crothers, D. M. (1994) Biochemistry 33, 936-942.
35. Sharp, K. A., & Englander, S. W. (1994) Trends Biochem. Sci. 19, 526-529.
36. Taylor, J. R. (1982) An Introduction to Error Analysis, pp 41-74, University Science Books, Mill Valley, CA.
37. Ughetto, G. (1988) in Anthracyclines and Anthracenedione Based Anticancer Agents (Lown, J. W., Ed.) pp 295-332, Elsevier, Amsterdam.
38. Wang, A. H.-J. (1992) Curr. Opin. Struct. Biol. 2, 361-368.
39. Wang, A. H.-J. (1993) in Molecular Aspects of Anticancer Drug-DNA Interactions (Neidle, S., & Waring, M., Eds.) Vol. 1, pp 32-53, CRC Press, Boca Raton, FL.
40. Weiss, R. B. (1992) Semin. Oncol. 19, 670-686.
41. Williams, L. D., Egli, M., Gao, Q., & Rich, A. (1992) in Structure &. Function (Sarma, R. H., & Sarma, M. H., Eds.) Vol. 1, pp 107-125, Adenine Press, Schenectady, NY.
42. Williams, D. H., Searle, M. S., Mackay, J. P., Gerhard, U., & Maplestone, R. A. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1172-1178.